Association of MASLD with chronic kidney disease according to metabolic profiles and fibrosis severity: a KNHANES analysis.
文献摘要
Background Metabolic dysfunction-associated steatotic liver disease (MASLD) is increasingly recognized as a multisystem metabolic disorder with extrahepatic manifestations, including chronic kidney disease (CKD). However, population-level evidence on the renal impact of metabolic heterogeneity and fibrosis severity in MASLD remains limited. We aimed to evaluate the association between MASLD and prevalent CKD and to examine the contributions of metabolic components and liver fibrosis severity. Methods We analyzed 17,229 adults (≥19 years) from the Korea National Health and Nutrition Examination Survey (KNHANES) 2011-2014. MASLD was defined as hepatic steatosis (hepatic steatosis index ≥36) with at least one cardiometabolic risk factor. CKD was defined as estimated glomerular filtration rate Results MASLD was associated with CKD (adjusted OR, 2.47; 95% CI, 1.76-3.47; p Conclusion MASLD was associated with prevalent CKD. The association with prevalent CKD within MASLD varied according to metabolic profiles and fibrosis severity, highlighting the importance of risk stratification and integrated liver-kidney management.